We are live on ! Find out more
IBRX icon

ImmunityBio
IBRX

126 hedge funds and large institutions have $311M invested in ImmunityBio in 2021 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 51 increasing their positions, 26 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

96% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 26

25% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 16

0.93% more ownership

Funds ownership: 7.23% → 8.16% (+0.93%)

1% more funds holding

Funds holding: 125 → 126 (+1)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

20% less capital invested

Capital invested by funds: $390M → $311M (-$78.7M)

61% less call options, than puts

Call options by funds: $5.03M | Put options by funds: $13M

Holders
126
Holders Change
+1
Holders Change %
+0.8%
% of All Funds
2.21%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
20
Increased
51
Reduced
26
Closed
16
Calls
$5.03M
Puts
$13M
Net Calls
-$7.96M
Net Calls Change
+$3.73M

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$16.2M
2
State Street
State Street
Massachusetts
+$12.4M
3
JP Morgan Chase
JP Morgan Chase
New York
+$6.3M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$3.23M
5
BlackRock
BlackRock
New York
+$3.06M

Top Sellers

1
First Trust Advisors
First Trust Advisors
Illinois
-$3.57M
2
N
Nuveen
North Carolina
-$3.43M
3
CSS
Cubist Systematic Strategies
Connecticut
-$1.43M
4
Citigroup
Citigroup
New York
-$1.27M
5
EGM
Engineers Gate Manager
New York
-$1.25M
Name Holding Trade Value Shares
Change 		Change in
Stake
Federated Hermes
101
Federated Hermes
Pennsylvania
$44K -$374 -34 -0.7%
IUHSA
102
Itau Unibanco Holding S.A.
Brazil
$40K +$15.3K +1,394 +52%
US Bancorp
103
US Bancorp
Minnesota
$25K -$15.4K -1,398 -35%
Northwestern Mutual Wealth Management
104
Northwestern Mutual Wealth Management
Wisconsin
$20K – – –
CAPTRUST Financial Advisors
105
CAPTRUST Financial Advisors
North Carolina
$19K – – –
WOC
106
West Oak Capital
California
$15K – – –
Bank Julius Baer & Co
107
Bank Julius Baer & Co
Switzerland
$15K +$319 +29 +2%
OSAM
108
O'Shaughnessy Asset Management
Connecticut
$14K – – –
HI
109
Harbour Investments
Wisconsin
$13K +$11 +1 +0.1%
LC
110
Lindbrook Capital
California
$10K – – –
NSIM
111
North Star Investment Management
Illinois
$10K +$10.9K +990 +9,900%
GG
112
Gleason Group
Kentucky
$10K +$11K +1,000 New
SWM
113
Spire Wealth Management
Virginia
$6K – – –
AAP
114
Arax Advisory Partners
Colorado
$6K +$6.6K +600 New
MCM
115
Manchester Capital Management
Vermont
$3K – – –
OIA
116
Optimum Investment Advisors
Illinois
$3K – – –
PA
117
PSI Advisors
Florida
$3K +$3.85K +350 New
AF
118
Advisornet Financial
Minnesota
$2K – – –
CFA
119
Carroll Financial Associates
North Carolina
$2K – – –
PNC Financial Services Group
120
PNC Financial Services Group
Pennsylvania
$2K – – –
BWM
121
BerganKDV Wealth Management
Minnesota
$1K – – –
KTC
122
Kistler-Tiffany Companies
Pennsylvania
$1K – – –
KIG
123
Kowal Investment Group
Wisconsin
$1K +$1.14K +104 New
Koshinski Asset Management
124
Koshinski Asset Management
Illinois
$399 +$451 +41 New
First Trust Advisors
125
First Trust Advisors
Illinois
– -$3.57M -250,096 Closed
2 3 4
5
6

IBRX Hedge Fund Activity: Q3 2021 in Review

126 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in ImmunityBio (IBRX) for Q3 2021, worth a combined $311M — down 20% from $390M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new IBRX positions and 16 closed out — a net gain of 4 holders — while 51 added to existing stakes and 26 trimmed.

The largest buyer was Vanguard Group, adding an estimated $16.2M. The largest seller was First Trust Advisors, exiting entirely with an estimated $3.57M sold.

  • 126 institutional investors held ImmunityBio (IBRX) as of Q3 2021, up from 125 in Q2 2021.
  • Funds reported $311M of ImmunityBio stock for Q3 2021, down 20% quarter-over-quarter.
  • 20 funds opened new ImmunityBio positions in Q3 2021 and 16 closed out, a net change of +4 holders.
  • The largest ImmunityBio buyer in Q3 2021 was Vanguard Group, an estimated $16.2M added.
  • The largest ImmunityBio seller in Q3 2021 was First Trust Advisors, an estimated $3.57M sold.

Based on aggregated 13F filings for Q3 2021.